The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Serum insulin‐like growth factor‐Ilevels are associated with improved white matter recovery after traumatic brain injury
Abstract
Objective: Traumatic brain injury (TBI) is a common disabling condition with limited treatment options. Diffusion tensor imaging measures recovery of axonal injury in white matter (WM) tracts after TBI. Growth hormone deficiency (GHD) after TBI may impair axonal and neuropsychological recovery, and serum insulin‐like growth factor‐I (IGF‐I) may mediate this effect. We conducted a longitudinal study to determine the effects of baseline serum IGF‐I concentrations on WM tract and neuropsychological recovery after TBI. Methods: Thirty‐nine adults after TBI (84.6% male, median age = 30.5 years, 87.2% moderate–severe, median time since TBI = 16.3 months, n = 4 with GHD) were scanned twice, 13.3 months (range = 12.1–14.9) apart, and 35 healthy controls were scanned once. Symptom and quality of life questionnaires and cognitive assessments were completed at both visits (n = 33). Our main outcome measure was fractional anisotropy (FA), a measure of WM tract integrity, in a priori regions of interest: splenium of corpus callosum (SPCC) and posterior limb of internal capsule (PLIC). Results: At baseline, FA was reduced in many WM tracts including SPCC and PLIC following TBI compared to controls, indicating axonal injury, with longitudinal increases indicating axonal recovery. There was a significantly greater increase in SPCC FA over time in patients with serum IGF‐I above versus below the median for age. Only the higher IGF‐I group had significant improvements in immediate verbal memory recall over time. Interpretation: WM recovery and memory improvements after TBI were greater in patients with higher serum IGF‐I at baseline. These findings suggest that the growth hormone/IGF‐I system may be a potential therapeutic target following TBI. Ann Neurol 2017;82:30–43
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Accordingly, reduced plasma IGF-1 levels have been correlated with cognitive impairments in TBI patients (Arwert et al., 2005; Feeney et al., 2017).”
From Acute neuroendocrine changes after traumatic brain injury (2024) · cites this paper as Feeney et al., 2017
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Salience network integrity predicts default mode network function after traumatic brain injury
Bonnelle, V., Ham, T. E., Leech, R., Kinnunen, K. M., Mehta, M. A., Greenwood, R. J., & Sharp, D. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113455109 · Cited by 606
Self-citationÅberg, N. D., Brywe, K. G., & Isgaard, J. (2006) · The Scientific World JOURNAL · doi:10.1100/tsw.2006.22 · Cited by 387
McMillan, T. M., Teasdale, G. M., & Stewart, E. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-302746 · Cited by 315 · cited 1×
“Many more suffer long-term cognitive and psychological problems with variable natural history.(2) A major pathological hallmark of TBI is diffuse axonal injury (DAI), resulting from shearing forces sustained during the injury.”
BackgroundEffect of growth hormone replacement therapy on cognition after traumatic brain injury
High, W. M., Briones-Galang, M., Clark, J. A., Gilkison, C., Mossberg, K. A., Zgaljardic, D. J., Masel, B. E., & Urban, R. J. (2010) · Journal of Neurotrauma · doi:10.1089/neu.2009.1253 · Cited by 176
Kokshoorn, N. E., Wassenaar, M. J. E., Biermasz, N. R., Roelfsema, F., Smit, J. W. A., Romijn, J. A., & Pereira, A. M. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-0601 · Cited by 129 · cited 5×
“%) after moderate–severe blast TBI in soldiers.20 The exact diagnostic criteria and use of body mass index (BMI)-dependent cut-offs for endocrine tests are, however, important when determining risk factors, especially for GHD.15,17,20,21 GH has several targets within the brain.22–24 Effects are direct or mediated thro…”
BackgroundInfluentialCHRONIC HYPOPITUITARISM AFTER TRAUMATIC BRAIN INJURY: RISK ASSESSMENT AND RELATIONSHIP TO OUTCOME
Bavisetty, S., McArthur, D. L., Dusick, J. R., Wang, C., Cohan, P., Boscardin, W. J., Swerdloff, R., Levin, H., Chang, D. J., Muizelaar, J. P., et al. (2008) · Neurosurgery · doi:10.1227/01.neu.0000325870.60129.6a · Cited by 126
Reimunde, P., Quintana, A., Castañón, B., Casteleiro, N., Vilarnovo, Z., Otero, A., Devesa, A., Otero-Cepeda, X. L., & Devesa, J. (2011) · Brain Injury · doi:10.3109/02699052.2010.536196 · Cited by 100
Growth hormone replacement therapy in patients with traumatic brain injury
Moreau, O. K., Cortet-Rudelli, C., Yollin, E., Merlen, E., Daveluy, W., & Rousseaux, M. (2013) · Journal of Neurotrauma · doi:10.1089/neu.2012.2705 · Cited by 94
Pituitary dysfunction after blast traumatic brain injury: The UK BIOSAP study
Baxter, D., Sharp, D. J., Feeney, C., Papadopoulou, D., Ham, T. E., Jilka, S., Hellyer, P. J., Patel, M. C., Bennett, A. N., Mistlin, A., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23958 · Cited by 81 · cited 20×
“%) after moderate–severe blast TBI in soldiers.20 The exact diagnostic criteria and use of body mass index (BMI)-dependent cut-offs for endocrine tests are, however, important when determining risk factors, especially for GHD.15,17,20,21 GH has several targets within the brain.22–24 Effects are direct or mediated thro…”
BackgroundMethodResultInfluentialSelf-citationMaric, N. P., Doknic, M., Pavlovic, D., Pekic, S., Stojanovic, M., Jasovic-Gasic, M., & Popovic, V. (2010) · Journal of Endocrinological Investigation · doi:10.1007/bf03350340 · Cited by 81
Gardner, C. J., Mattsson, A. F., Daousi, C., Korbonits, M., Koltowska-Haggstrom, M., & Cuthbertson, D. J. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0654 · Cited by 65
Low prevalence of hypopituitarism after traumatic brain injury: a multicenter study
Kokshoorn, N. E., Smit, J. W. A., Nieuwlaat, W. A., Tiemensma, J., Bisschop, P. H., Groote Veldman, R., Roelfsema, F., Franken, A. A. M., Wassenaar, M. J. E., Biermasz, N. R., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0365 · Cited by 65
Amnesia following infarction in the right retrosplenial region
Yasuda, Y., Watanabe, T., Tanaka, H., Tadashi, I., & Akiguchi, I. (1997) · Clinical Neurology and Neurosurgery · doi:10.1016/s0303-8467(97)80005-4 · Cited by 38
Research works printed but not linked: 45
- 10.1136/jnnp-2012-303015 · DOI
- 10.1007/BF00571509 · DOI · Paper page
- 10.1097/WCO.0b013e328359488f · DOI
- 10.1038/nrneurol.2014.15 · DOI · Paper page
- 10.1136/jnnp.2010.222232 · DOI
- 10.1002/ana.23824 · DOI
- 10.1523/JNEUROSCI.4692-12.2013 · DOI · Paper page
- 10.1093/brain/awm294 · DOI · Paper page
- 10.1093/brain/awq347 · DOI · Paper page
- 10.1523/JNEUROSCI.1163-11.2011 · DOI · Paper page
- 10.1097/WCO.0b013e32834cd523 · DOI
- 10.1111/j.1365-2265.2006.02517.x · DOI · Paper page
- 10.1210/jc.2013-2397 · DOI · Paper page
- 10.1089/neu.2015.3998 · DOI
- Nemes O, 2015, Predictors of post‐traumatic pituitary failure during long‐term follow‐up, Hormones (Athens), 14, 383, 10.14310/horm.2002.1564 · DOI · Paper page
- 10.1210/jc.2009-1134 · DOI
- 10.1016/S1096-6374(00)80010-6 · DOI
- 10.1038/nrendo.2013.78 · DOI
- 10.1159/000184753 · DOI
- 10.1093/brain/awr305 · DOI
- 10.1016/S0306-4530(03)00151-3 · DOI
- 10.1016/j.yhbeh.2004.11.015 · DOI · Paper page
- Lasaite L, 2004, Psychological functioning after growth hormone therapy in adult growth hormone deficient patients: endocrine and body composition correlates, Medicina, 40, 740
- 10.1161/STROKEAHA.110.600783 · DOI
- 10.1210/jc.2010-2802 · DOI
- 10.1002/glia.20829 · DOI · Paper page
- 10.1159/000262529 · DOI
- 10.1089/neu.2006.0245 · DOI · Paper page
- 10.1002/hbm.10062 · DOI · Paper page
- 10.1016/j.neuroimage.2004.07.051 · DOI · Paper page
- 10.1016/j.neuroimage.2008.10.055 · DOI · Paper page
- 10.1002/mrm.10609 · DOI · Paper page
- 10.1016/j.neuroimage.2006.02.024 · DOI · Paper page
- 10.1002/hbm.1058 · DOI · Paper page
- 10.1007/s00221-006-0438-2 · DOI · Paper page
- 10.1002/jnr.20719 · DOI
- Drake WM, 2001, Optimizing GH therapy in adults and children, Endocr Rev, 22, 425, 10.1210/edrv.22.4.0438 · DOI · Paper page
- 10.1016/j.cortex.2008.03.007 · DOI
- 10.1093/brain/awr175 · DOI · Paper page
- 10.3988/jcn.2007.3.1.62 · DOI · Paper page
- Huang X, 2015, Cognitive impairments associated with corpus callosum infarction: a ten cases study, Int J Clin Exp Med, 8, 21991
- 10.1177/1352458511398265 · doi:10.1177/1352458511398265
- 10.1002/hbm.21499 · DOI
- 10.1093/brain/aww241 · DOI
- 10.1016/j.neuroimage.2008.08.030 · DOI
Cited by
Acute neuroendocrine changes after traumatic brain injury
Magyar-Sumegi, Z. D., Stankovics, L., Lendvai-Emmert, D., Czigler, A., Hegedus, E., Csendes, M., Toth, L., Ungvari, Z., Buki, A., & Toth, P. (2024) · Brain and Spine · doi:10.1016/j.bas.2024.102830 · Cited by 23
Metadata
- Authors
- Feeney, C., Sharp, D. J., Hellyer, P. J., Jolly, A. E., Cole, J. H., Scott, G., Baxter, D., Jilka, S., Ross, E., Ham, T. E., Jenkins, P. O., Li, L. M., Gorgoraptis, N., Midwinter, M., & Goldstone, A. P.
- Affiliations
- Computational, Cognitive, and Clinical Neuroimaging Laboratory, Division of Brain Sciences, Imperial College London Hammersmith Hospital London, United Kingdom
- Royal Centre for Defence Medicine, Academic Department of Military Surgery and Trauma Birmingham, United Kingdom
- ORCID
- Cole, James H.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2017-07
- Volume
- 82
- Issue
- 1
- Pages
- 30-43
- ISSN
- 0364-5134
- 1531-8249
- Cited by
- 32
- References
- 13
- Language
- en
- Funders
- Medical Research Council
- National Institute for Health Research
- Pfizer
- Wellcome Trust
- National Institute on Handicapped Research
- Academy of Medical Sciences
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
